# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010089
Filing Date
2025-05-14
Accepted
2025-05-14 06:34:20
Documents
52
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 667947
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 11505
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 12287
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 6810
5 | EX-32.2 | ex32-2.htm | EX-32.2 | 6992
| Complete submission text file | 0001641172-25-010089.txt |  | 4269456

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | kapa-20250331.xsd | EX-101.SCH | 41499
7 | XBRL CALCULATION FILE | kapa-20250331_cal.xml | EX-101.CAL | 29575
8 | XBRL DEFINITION FILE | kapa-20250331_def.xml | EX-101.DEF | 158545
9 | XBRL LABEL FILE | kapa-20250331_lab.xml | EX-101.LAB | 353174
10 | XBRL PRESENTATION FILE | kapa-20250331_pre.xml | EX-101.PRE | 258048
54 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 570821

Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42275 | Film No.: 25942550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)